A commentary on 'Survival benefit of liver resection following complete response to transarterial chemoembolization for intermediate-stage hepatocellular carcinoma: a retrospective, multicenter, cohort study'

被引：0
|
作者：
Gao, Fengwei [1 ,2 ,3 ]
Zhao, Xin [4 ]
Xie, Qingyun [4 ]
Yang, Jiayin [1 ,2 ,3 ]
Wu, Hong [1 ,2 ,3 ,5 ]
机构：
[1] Sichuan Univ, West China Hosp, Liver Transplantat Ctr, Chengdu, Peoples R China
[2] Sichuan Univ, West China Hosp, Canc Ctr, Chengdu, Peoples R China
[3] Collaborat Innovat Ctr Biotherapy, Chengdu, Peoples R China
[4] Peoples Hosp Leshan, Dept Hepatopancreatobiliary Surg, Leshan, Peoples R China
[5] Liver Transplantat Ctr, 37 Guoxue Lane, Chengdu 610041, Sichuan, Peoples R China
来源：
INTERNATIONAL JOURNAL OF SURGERY | 2024年 / 110卷 / 04期
关键词：
D O I：
10.1097/JS9.0000000000001052
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：2442 / 2443
页数：2
相关论文
共 50 条
  • [21] New intermediate-stage subclassification for patients with hepatocellular carcinoma treated with transarterial chemoembolization
    Kim, Jin Hyoung
    Shim, Ju Hyun
    Lee, Han Chu
    Sung, Kyu-Bo
    Ko, Heung-Kyu
    Ko, Gi-young
    Gwon, Dong Il
    Kim, Jong Woo
    Lim, Yung-Suk
    Park, Seong Ho
    LIVER INTERNATIONAL, 2017, 37 (12) : 1861 - 1868
  • [22] Clinical-radiomics predictors to identify the suitability of transarterial chemoembolization treatment in intermediate-stage hepatocellular carcinoma: A multicenter study
    Dan-Dan Wang
    Jin-Feng Zhang
    Lin-Han Zhang
    Meng Niu
    Hui-Jie Jiang
    Fu-Cang Jia
    Shi-Ting Feng
    Hepatobiliary&PancreaticDiseasesInternational, 2023, 22 (06) : 594 - 604
  • [23] A Prognostic Score for Patients with Intermediate-Stage Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
    Ogasawara, Sadahisa
    Chiba, Tetsuhiro
    Ooka, Yoshihiko
    Kanogawa, Naoya
    Motoyama, Tenyu
    Suzuki, Eiichiro
    Tawada, Akinobu
    Azemoto, Ryosaku
    Shinozaki, Masami
    Yoshikawa, Masaharu
    Yokosuka, Osamu
    PLOS ONE, 2015, 10 (04):
  • [24] Efficacy of Sorafenib in Intermediate-Stage Hepatocellular Carcinoma Patients Refractory to Transarterial Chemoembolization
    Ogasawara, Sadahisa
    Chiba, Tetsuhiro
    Ooka, Yoshihiko
    Kanogawa, Naoya
    Motoyama, Tenyu
    Suzuki, Eiichiro
    Tawada, Akinobu
    Kanai, Fumihiko
    Yoshikawa, Masaharu
    Yokosuka, Osamu
    ONCOLOGY, 2014, 87 (06) : 330 - 341
  • [25] Clinical-radiomics predictors to identify the suitability of transarterial chemoembolization treatment in intermediate-stage hepatocellular carcinoma: A multicenter study
    Wang, Dan-Dan
    Zhang, Jin-Feng
    Zhang, Lin-Han
    Niu, Meng
    Jiang, Hui-Jie
    Jia, Fu-Cang
    Feng, Shi-Ting
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2023, 22 (06) : 594 - 604
  • [26] TRANSARTERIAL CHEMOEMBOLIZATION IN THE INTERMEDIATE STAGE OF HEPATOCELLULAR CARCINOMA: SURVIVAL ANALYSIS
    Tajibaev, T. K.
    Medeubekov, U. Sh
    Chormanov, A. T.
    Sagatov, I. Y.
    Kaniev, Sh A.
    Issamatov, B. K.
    Baimakhanov, B. B.
    NEW ARMENIAN MEDICAL JOURNAL, 2019, 13 (02): : 111 - 114
  • [27] A multicenter cohort study on transarterial chemoembolization with or without sorafenib for intermediate-stage hepatocellular carcinoma: Reconsidering combination-therapy trial design.
    Zhao, Yan
    Li, Hailiang
    Bai, Wei
    Liu, Jueshi
    Lv, Weifu
    Guan, Sheng
    Qin, Xiao
    Wang, Wenhui
    Ren, Weixin
    Mu, Wei
    Guo, Weidong
    Gu, Shanzhi
    Ma, Yilong
    Yin, Zhanxin
    Guo, Wengang
    Wang, Yongji
    Xia, Jielai
    Duran, Rafael
    Fan, Daiming
    Han, Guohong
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [28] THE COMPARISON BETWEEN OVERALL SURVIVAL OF TRANSARTERIAL CHEMOEMBOLIZATION AND BEST SUPPORTIVE CARE IN INTERMEDIATE-STAGE HEPATOCELLULAR CARCINOMA
    Akarapatima, Keerati
    Chang, Arunchai
    Prateepchaiboon, Tanaporn
    Pungpipattrakul, Nuttanit
    Songjamrat, Apiradee
    Pakdeejit, Songklod
    Rattanasupar, Attapon
    GUT, 2021, 70 : A73 - A74
  • [29] Transarterial- chemoembolization remains an effective therapy for intermediate-stage hepatocellular carcinoma with preserved liver function
    Saito, Natsuhiko
    Tanaka, Toshihiro
    Nishiohuku, Hideyuki
    Sato, Takeshi
    Masada, Tetsuya
    Matsumoto, Takeshi
    Anai, Hiroshi
    Sakaguchi, Hiroshi
    Sueyoshi, Satoru
    Marugami, Nagaaki
    Kichikawa, Kimihiko
    HEPATOLOGY RESEARCH, 2020, 50 (10) : 1176 - 1185
  • [30] Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular Carcinoma
    Peng, Zhenwei
    Chen, Shuling
    Xiao, Han
    Wang, Yu
    Li, Jiaping
    Mei, Jie
    Chen, Zebin
    Zhou, Qian
    Feng, Shiting
    Chen, Minshan
    Qian, Guojun
    Peng, Sui
    Kuang, Ming
    RADIOLOGY, 2019, 292 (01) : 237 - 247
12345